BSEAGM/EGMResults2d ago
Pfizer Ltd
Pursuant to Regulation 44 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015, we submit herewith the consolidated Scrutinizer''s Report of the votes cast through ....
Pfizer Ltd's 75th Annual General Meeting was held on July 28, 2026, with a total of 1,05,890 shareholders on record. The meeting was attended by 46 shareholders through video conferencing, with 63.92% being promoters and 0.04% being public shareholders. The resolutions were passed with requisite majority, with all shareholders voting in favor of the resolutions.
BSEAGM/EGM3d ago
Pfizer Ltd
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, please find enclosed proceedings of the 75th Annual General Meeting of the Company held on July 28, 2026.
Pfizer Ltd held its 75th Annual General Meeting on July 28, 2026, through video conferencing. The meeting was chaired by Mr. Pradip Shah, and the requisite quorum was present. The Chairman paid tribute to Late Mr. R.A. Shah, and the Members joined in observing a minute's silence. The proceedings of the meeting were recorded, and the video recording will be made available on the Company's website. The Members were provided the facility of remote e-voting on the resolutions proposed in the Notice of the Annual General Meeting.
BSEBoard MeetingResults4d ago
Pfizer Ltd
Pursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Unaudited Financial Results of the Company for ....
Pfizer Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, which were approved by the Board of Directors at their meeting held on July 28, 2026. The results include a statement of unaudited financial results, which has been reviewed by the statutory auditors, B S R & Co. LLP.
BSECompany UpdateMgmt Change4d ago
Pfizer Ltd
Intimation of Resignation of Mr. Amit Agarwal, Executive Director -Finance & Chief Financial Officer
Pfizer Ltd's Executive Director - Finance & Chief Financial Officer, Mr. Amit Agarwal, has resigned from the services of the company, effective October 8, 2026, to pursue an opportunity outside Pfizer Limited.